Immunomedics, Inc. (IMMU) Posts Mixed Q2 Results
Immunomedics, Inc. (NASDAQ: IMMU) reported Q2 EPS of ($0.07), $0.02 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)